Fate Therapeutics Inc. (FATE) NASDAQ
$3.90 (0.40) (-9.30%)
Market Cap: $489.41M
As of 04/25/24 02:09 PM EDT. Market open.
Fate Therapeutics Inc. (FATE)
NASDAQ
$3.90
(0.40) (-9.30%)
Market Cap: $489.41M
As of 04/25/24 02:09 PM EDT. Market open.
fate therapeutics is applying leading expertise in stem cell biology and conventional drug discovery to develop small molecule and biologic drugs that: 1) activate stem cells in the body to stimulate healing and repair or block cancer growth; and 2) create and differentiate "pharmaceutical grade"? ips cells to enable their use in drug discovery and development, disease modeling, and eventually ... read more
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Dulac Edward J III | Chief Financial Officer | Mar 04, 2024 | Sale | $7.77 | 2,447 | 19,013 | 101,479 | Mar 05, 2024, 04:24 PM |
Dulac Edward J III | Chief Financial Officer | Jan 29, 2024 | Sale | $5.00 | 1,849 | 9,245 | 103,926 | Jan 30, 2024, 04:01 PM |
TAHL CINDY | General Counsel and Secretary | Jan 09, 2024 | Sale | $4.37 | 10,874 | 47,519 | 142,361 | Jan 10, 2024, 04:30 PM |
Valamehr Bahram | Chief R&D Officer | Jan 09, 2024 | Sale | $4.38 | 11,271 | 49,367 | 158,069 | Jan 10, 2024, 04:30 PM |
Wolchko J Scott | President and CEO | Jan 09, 2024 | Sale | $4.37 | 14,391 | 62,889 | 371,248 | Jan 10, 2024, 04:29 PM |
Dulac Edward J III | Chief Financial Officer | Jan 09, 2024 | Sale | $4.37 | 7,028 | 30,712 | 105,775 | Jan 10, 2024, 04:29 PM |
Dulac Edward J III | Chief Financial Officer | Jan 02, 2024 | Sale | $3.66 | 5,182 | 18,966 | 112,803 | Jan 03, 2024, 04:03 PM |
Redmile Group, LLC | Director | Dec 26, 2023 | Option Exercise | $3.72 | 3,310,740 | 12,315,953 | 13,135,758 | Dec 28, 2023, 09:30 PM |
Redmile Group, LLC | Director | Dec 26, 2023 | Buy | $3.72 | 44,630 | 166,024 | 13,180,388 | Dec 28, 2023, 09:30 PM |
Dulac Edward J III | Chief Financial Officer | Dec 18, 2023 | Sale | $3.50 | 1,585 | 5,548 | 117,985 | Dec 19, 2023, 04:01 PM |
TAHL CINDY | General Counsel and Secretary | Nov 09, 2023 | Sale | $2.40 | 24,363 | 58,471 | 153,235 | Nov 13, 2023, 04:01 PM |
Dulac Edward J III | Chief Financial Officer | Aug 18, 2023 | Sale | $2.80 | 4,718 | 13,210 | 119,570 | Aug 21, 2023, 04:02 PM |
Xu Yuan | Director | Aug 04, 2023 | Sale | $3.71 | 632 | 2,345 | 9,302 | Aug 07, 2023, 04:01 PM |
Powl Brian T. | Chief Commercial Officer | Jul 05, 2023 | Sale | $4.87 | 3,854 | 18,769 | 41,146 | Jul 06, 2023, 05:19 PM |
Dulac Edward J III | Chief Financial Officer | Jul 05, 2023 | Sale | $4.83 | 5,182 | 25,029 | 124,288 | Jul 06, 2023, 05:18 PM |
Xu Yuan | Director | Jun 14, 2023 | Sale | $5.58 | 3,460 | 19,307 | 9,934 | Jun 15, 2023, 04:05 PM |
Redmile Group, LLC | Director | Apr 21, 2023 | Buy | $6.18 | 256,639 | 1,586,029 | 13,135,758 | Apr 21, 2023, 09:55 PM |
Redmile Group, LLC | Director | Apr 20, 2023 | Buy | $5.99 | 20,000 | 119,800 | 12,879,119 | Apr 21, 2023, 09:55 PM |
Chu Yu-Waye | Chief Medical Officer | Apr 18, 2023 | Sale | $6.57 | 2,532 | 16,648 | 142,993 | Apr 19, 2023, 04:07 PM |
Redmile Group, LLC | Director | Apr 14, 2023 | Option Exercise | $5.84 | 10,984,770 | 64,151,058 | 12,833,419 | Apr 17, 2023, 09:30 PM |
Redmile Group, LLC | Director | Apr 14, 2023 | Buy | $6.00 | 25,700 | 154,200 | 12,859,119 | Apr 17, 2023, 09:30 PM |
Redmile Group, LLC | Director | Apr 14, 2023 | Sale | $5.84 | 302,339 | 1,765,660 | 12,833,419 | Apr 17, 2023, 09:30 PM |
MENDLEIN JOHN | Director | Jan 19, 2023 | Option Exercise | $1.37 | 28,461 | 38,992 | 311,231 | Jan 20, 2023, 04:14 PM |
MENDLEIN JOHN | Director | Jan 13, 2023 | Buy | $5.43 | 36,631 | 198,906 | 282,770 | Jan 13, 2023, 06:20 PM |
MENDLEIN JOHN | Director | Jan 11, 2023 | Buy | $5.67 | 88,048 | 499,232 | 246,139 | Jan 13, 2023, 06:20 PM |
Valamehr Bahram | Chief R&D Officer | Jan 12, 2023 | Option Exercise | $1.37 | 423 | 580 | 169,340 | Jan 13, 2023, 04:02 PM |
Wolchko J Scott | President and CEO | Jan 10, 2023 | Sale | $5.24 | 45,907 | 240,553 | 385,639 | Jan 11, 2023, 04:09 PM |
Valamehr Bahram | Chief R&D Officer | Jan 10, 2023 | Sale | $5.24 | 10,917 | 57,205 | 168,917 | Jan 11, 2023, 04:08 PM |
TAHL CINDY | General Counsel and Secretary | Jan 10, 2023 | Sale | $5.24 | 11,553 | 60,538 | 177,598 | Jan 11, 2023, 04:08 PM |
Plavsic Mark | Chief Technical Officer | Jan 10, 2023 | Sale | $5.24 | 3,418 | 17,910 | 123,705 | Jan 11, 2023, 04:07 PM |
Dulac Edward J III | Chief Financial Officer | Jan 10, 2023 | Sale | $5.24 | 7,331 | 38,414 | 129,470 | Jan 11, 2023, 04:06 PM |
Chu Yu-Waye | Chief Medical Officer | Jan 10, 2023 | Sale | $5.24 | 7,825 | 41,003 | 143,208 | Jan 11, 2023, 04:05 PM |
Dulac Edward J III | Chief Financial Officer | Aug 18, 2022 | Sale | $29.81 | 5,135 | 153,051 | 137,233 | Aug 19, 2022, 06:58 PM |
Wolchko J Scott | President and CEO | Jul 22, 2022 | Option Exercise | $2.70 | 6,246 | 16,864 | 437,792 | Jul 25, 2022, 06:18 PM |
Wolchko J Scott | President and CEO | Jul 21, 2022 | Option Exercise | $2.70 | 30,000 | 81,000 | 461,546 | Jul 25, 2022, 06:18 PM |
Wolchko J Scott | President and CEO | Jul 21, 2022 | Sale | $32.88 | 30,000 | 986,361 | 450,717 | Jul 25, 2022, 06:18 PM |
Wolchko J Scott | President and CEO | Jul 22, 2022 | Sale | $32.08 | 6,246 | 200,356 | 434,869 | Jul 25, 2022, 06:18 PM |
Valamehr Bahram | Chief R&D Officer | Jul 07, 2022 | Option Exercise | $2.73 | 17,158 | 46,841 | 196,992 | Jul 08, 2022, 04:51 PM |
Valamehr Bahram | Chief R&D Officer | Jul 07, 2022 | Sale | $30.23 | 17,158 | 518,686 | 179,834 | Jul 08, 2022, 04:51 PM |
Valamehr Bahram | Chief R&D Officer | Jul 06, 2022 | Option Exercise | $3.27 | 7,842 | 25,629 | 187,676 | Jul 07, 2022, 04:04 PM |
Valamehr Bahram | Chief R&D Officer | Jul 06, 2022 | Sale | $30.07 | 7,842 | 235,809 | 179,834 | Jul 07, 2022, 04:04 PM |
Agarwal Shefali | Director | Jun 07, 2022 | Sale | $21.89 | 841 | 18,409 | 1,840 | Jun 08, 2022, 04:03 PM |
MENDLEIN JOHN | Director | Jun 03, 2022 | Sale | $22.79 | 1,364 | 31,086 | 158,091 | Jun 06, 2022, 04:49 PM |
Jooss Karin | Director | Jun 03, 2022 | Sale | $22.82 | 1,483 | 33,842 | 1,198 | Jun 06, 2022, 04:48 PM |
HERSHBERG ROBERT | Director | Jun 03, 2022 | Sale | $22.75 | 672 | 15,288 | 2,009 | Jun 06, 2022, 04:45 PM |
COUGHLIN TIMOTHY | Director | Jun 03, 2022 | Sale | $22.81 | 1,439 | 32,824 | 57,632 | Jun 06, 2022, 04:43 PM |
Agarwal Shefali | Director | Jun 03, 2022 | Sale | $22.80 | 807 | 18,400 | 1,874 | Jun 06, 2022, 04:40 PM |
TAHL CINDY | General Counsel and Secretary | Jun 01, 2022 | Option Exercise | $6.55 | 25,000 | 163,750 | 214,151 | Jun 02, 2022, 04:04 PM |
TAHL CINDY | General Counsel and Secretary | Jun 01, 2022 | Sale | $22.96 | 25,000 | 574,000 | 189,151 | Jun 02, 2022, 04:04 PM |
Wolchko J Scott | President and CEO | Apr 22, 2022 | Option Exercise | $2.70 | 10,000 | 27,000 | 441,546 | Apr 25, 2022, 04:11 PM |
Wolchko J Scott | President and CEO | Apr 21, 2022 | Option Exercise | $2.70 | 30,000 | 81,000 | 461,546 | Apr 25, 2022, 04:11 PM |
Wolchko J Scott | President and CEO | Apr 22, 2022 | Sale | $34.59 | 10,000 | 345,911 | 432,384 | Apr 25, 2022, 04:11 PM |
Wolchko J Scott | President and CEO | Apr 21, 2022 | Sale | $35.00 | 30,000 | 1,049,881 | 438,831 | Apr 25, 2022, 04:11 PM |
Chu Yu-Waye | Chief Medical Officer | Apr 19, 2022 | Sale | $35.37 | 4,062 | 143,673 | 151,033 | Apr 21, 2022, 04:04 PM |
Valamehr Bahram | Chief R&D Officer | Mar 14, 2022 | Option Exercise | $2.73 | 25,000 | 68,250 | 204,834 | Mar 15, 2022, 04:27 PM |
Valamehr Bahram | Chief R&D Officer | Mar 14, 2022 | Sale | $31.07 | 25,000 | 776,733 | 188,156 | Mar 15, 2022, 04:27 PM |
MENDLEIN JOHN | Director | Mar 10, 2022 | Option Exercise | $1.63 | 31,562 | 51,446 | 191,017 | Mar 11, 2022, 04:58 PM |
MENDLEIN JOHN | Director | Mar 10, 2022 | Sale | $35.02 | 31,562 | 1,105,200 | 171,524 | Mar 11, 2022, 04:58 PM |
Wolchko J Scott | President and CEO | Jan 20, 2022 | Option Exercise | $2.70 | 30,000 | 81,000 | 461,546 | Feb 04, 2022, 05:59 PM |
Wolchko J Scott | President and CEO | Jan 21, 2022 | Option Exercise | $2.70 | 10,000 | 27,000 | 441,546 | Jan 24, 2022, 04:36 PM |
Wolchko J Scott | President and CEO | Jan 20, 2022 | Option Exercise | $2.73 | 30,000 | 81,900 | 461,546 | Jan 24, 2022, 04:36 PM |
Wolchko J Scott | President and CEO | Jan 21, 2022 | Sale | $38.02 | 10,000 | 380,200 | 431,546 | Jan 24, 2022, 04:36 PM |
Wolchko J Scott | President and CEO | Jan 20, 2022 | Sale | $40.21 | 30,000 | 1,206,300 | 431,546 | Jan 24, 2022, 04:36 PM |
Wolchko J Scott | President and CEO | Jan 11, 2022 | Sale | $48.68 | 14,566 | 709,027 | 436,065 | Jan 13, 2022, 04:09 PM |
TAHL CINDY | General Counsel and Secretary | Jan 11, 2022 | Sale | $48.53 | 5,419 | 262,975 | 156,385 | Jan 13, 2022, 04:08 PM |
Valamehr Bahram | Chief R&D Officer | Jan 11, 2022 | Sale | $48.50 | 4,570 | 221,655 | 146,950 | Jan 13, 2022, 04:07 PM |
Dulac Edward J III | Chief Financial Officer | Jan 11, 2022 | Sale | $48.45 | 1,770 | 85,757 | 109,024 | Jan 13, 2022, 04:06 PM |
Chu Yu-Waye | Senior VP Clinical Development | Jan 11, 2022 | Sale | $48.51 | 3,965 | 192,340 | 122,211 | Jan 13, 2022, 04:05 PM |
Wolchko J Scott | President and CEO | Jan 10, 2022 | Sale | $46.86 | 34,156 | 1,600,534 | 467,107 | Jan 12, 2022, 04:07 PM |
TAHL CINDY | General Counsel and Secretary | Jan 10, 2022 | Sale | $46.43 | 7,738 | 359,313 | 161,911 | Jan 12, 2022, 04:06 PM |
Valamehr Bahram | Chief R&D Officer | Jan 10, 2022 | Sale | $46.38 | 5,596 | 259,558 | 151,453 | Jan 12, 2022, 04:05 PM |
TAHL CINDY | General Counsel and Secretary | Jan 03, 2022 | Option Exercise | $6.55 | 50,000 | 327,500 | 219,006 | Jan 04, 2022, 04:03 PM |
TAHL CINDY | General Counsel and Secretary | Jan 03, 2022 | Sale | $59.34 | 50,000 | 2,966,853 | 214,579 | Jan 04, 2022, 04:03 PM |
Dulac Edward J III | Chief Financial Officer | Dec 20, 2021 | Option Exercise | $35.52 | 14,437 | 512,802 | 126,381 | Dec 21, 2021, 04:08 PM |
Dulac Edward J III | Chief Financial Officer | Dec 20, 2021 | Sale | $60.00 | 15,977 | 958,620 | 110,404 | Dec 21, 2021, 04:08 PM |
Valamehr Bahram | Chief R&D Officer | Dec 13, 2021 | Option Exercise | $2.73 | 25,000 | 68,250 | 181,698 | Dec 14, 2021, 04:18 PM |
Valamehr Bahram | Chief R&D Officer | Dec 13, 2021 | Sale | $47.66 | 25,000 | 1,191,406 | 179,598 | Dec 14, 2021, 04:18 PM |
Chu Yu-Waye | Senior VP Clinical Development | Dec 10, 2021 | Option Exercise | $16.32 | 7,500 | 122,400 | 133,258 | Dec 13, 2021, 05:53 PM |
Chu Yu-Waye | Senior VP Clinical Development | Dec 10, 2021 | Sale | $51.46 | 7,500 | 385,948 | 131,161 | Dec 13, 2021, 05:53 PM |
Wolchko J Scott | President and CEO | Nov 18, 2021 | Option Exercise | $2.70 | 20,000 | 54,000 | 413,793 | Nov 22, 2021, 05:45 PM |
Wolchko J Scott | President and CEO | Nov 18, 2021 | Sale | $54.27 | 20,000 | 1,085,400 | 393,793 | Nov 22, 2021, 05:45 PM |
Wolchko J Scott | President and CEO | Oct 22, 2021 | Option Exercise | $3.06 | 30,000 | 91,670 | 423,793 | Oct 25, 2021, 04:04 PM |
Wolchko J Scott | President and CEO | Oct 21, 2021 | Option Exercise | $2.73 | 30,000 | 81,900 | 423,793 | Oct 25, 2021, 04:04 PM |
Wolchko J Scott | President and CEO | Oct 22, 2021 | Sale | $58.88 | 30,000 | 1,766,400 | 393,793 | Oct 25, 2021, 04:04 PM |
Wolchko J Scott | President and CEO | Oct 21, 2021 | Sale | $60.22 | 30,000 | 1,806,560 | 408,558 | Oct 25, 2021, 04:04 PM |
TAHL CINDY | General Counsel and Secretary | Oct 01, 2021 | Option Exercise | $6.55 | 50,000 | 327,500 | 158,048 | Oct 04, 2021, 04:12 PM |
TAHL CINDY | General Counsel and Secretary | Oct 01, 2021 | Sale | $58.83 | 50,000 | 2,941,462 | 141,736 | Oct 04, 2021, 04:12 PM |
Dulac Edward J III | Chief Financial Officer | Sep 28, 2021 | Option Exercise | $35.52 | 17,325 | 615,384 | 71,864 | Sep 30, 2021, 04:14 PM |
Dulac Edward J III | Chief Financial Officer | Sep 28, 2021 | Sale | $62.53 | 19,460 | 1,216,834 | 52,404 | Sep 30, 2021, 04:14 PM |
Valamehr Bahram | Chief Development Officer | Sep 13, 2021 | Option Exercise | $2.73 | 25,000 | 68,250 | 120,740 | Sep 14, 2021, 04:01 PM |
Valamehr Bahram | Chief Development Officer | Sep 13, 2021 | Sale | $66.29 | 25,000 | 1,657,257 | 104,931 | Sep 14, 2021, 04:01 PM |
Wolchko J Scott | President and CEO | Aug 19, 2021 | Option Exercise | $4.84 | 20,000 | 96,700 | 413,793 | Aug 20, 2021, 04:02 PM |
Wolchko J Scott | President and CEO | Aug 19, 2021 | Sale | $88.01 | 20,000 | 1,760,204 | 393,793 | Aug 20, 2021, 04:02 PM |
Dulac Edward J III | Chief Financial Officer | Aug 19, 2021 | Sale | $88.26 | 3,474 | 306,602 | 56,076 | Aug 20, 2021, 04:01 PM |
Wolchko J Scott | President and CEO | Jul 23, 2021 | Option Exercise | $4.14 | 30,000 | 124,100 | 423,793 | Jul 26, 2021, 04:05 PM |
Wolchko J Scott | President and CEO | Jul 22, 2021 | Option Exercise | $2.73 | 30,000 | 81,900 | 423,793 | Jul 26, 2021, 04:05 PM |
Wolchko J Scott | President and CEO | Jul 23, 2021 | Sale | $85.28 | 30,000 | 2,558,538 | 393,793 | Jul 26, 2021, 04:05 PM |
Wolchko J Scott | President and CEO | Jul 22, 2021 | Sale | $86.05 | 30,000 | 2,581,575 | 417,166 | Jul 26, 2021, 04:05 PM |
TAHL CINDY | General Counsel and Secretary | Jul 01, 2021 | Option Exercise | $5.64 | 55,534 | 313,242 | 163,582 | Jul 02, 2021, 07:08 PM |
TAHL CINDY | General Counsel and Secretary | Jul 01, 2021 | Sale | $85.24 | 55,534 | 4,733,743 | 163,482 | Jul 02, 2021, 07:08 PM |
Chu Yu-Waye | Senior VP Clinical Development | Apr 16, 2021 | Sale | $83.30 | 3,275 | 272,809 | 67,200 | Apr 20, 2021, 04:00 PM |
TAHL CINDY | See Remarks | Apr 01, 2021 | Option Exercise | $3.21 | 30,000 | 96,199 | 138,048 | Apr 02, 2021, 06:03 PM |
TAHL CINDY | See Remarks | Apr 01, 2021 | Sale | $83.81 | 30,000 | 2,514,329 | 137,048 | Apr 02, 2021, 06:03 PM |
Valamehr Bahram | Chief Development Officer | Mar 15, 2021 | Option Exercise | $2.90 | 25,000 | 72,500 | 120,740 | Mar 16, 2021, 04:05 PM |
Valamehr Bahram | Chief Development Officer | Mar 15, 2021 | Sale | $92.35 | 25,000 | 2,308,772 | 116,783 | Mar 16, 2021, 04:05 PM |
Shoemaker Daniel D | Chief Scientific Officer | Mar 08, 2021 | Sale | $81.74 | 25,000 | 2,043,428 | 94,722 | Mar 09, 2021, 04:02 PM |
Wolchko J Scott | President and CEO | Feb 18, 2021 | Option Exercise | $6.62 | 20,000 | 132,400 | 413,793 | Feb 19, 2021, 04:07 PM |
Wolchko J Scott | President and CEO | Feb 18, 2021 | Sale | $102.01 | 20,000 | 2,040,256 | 412,392 | Feb 19, 2021, 04:07 PM |
Wolchko J Scott | President and CEO | Jan 21, 2021 | Option Exercise | $2.73 | 30,000 | 81,900 | 423,793 | Jan 22, 2021, 06:23 PM |
Wolchko J Scott | President and CEO | Jan 22, 2021 | Option Exercise | $5.32 | 30,000 | 159,700 | 423,793 | Jan 22, 2021, 06:23 PM |
Wolchko J Scott | President and CEO | Jan 22, 2021 | Sale | $98.29 | 30,000 | 2,948,613 | 411,026 | Jan 22, 2021, 06:23 PM |
Wolchko J Scott | President and CEO | Jan 21, 2021 | Sale | $103.05 | 30,000 | 3,091,361 | 421,253 | Jan 22, 2021, 06:23 PM |
TAHL CINDY | General Counsel and Secretary | Jan 19, 2021 | Option Exercise | $2.90 | 35,000 | 101,500 | 125,035 | Jan 21, 2021, 07:08 PM |
TAHL CINDY | General Counsel and Secretary | Jan 19, 2021 | Sale | $114.76 | 35,000 | 4,016,643 | 109,200 | Jan 21, 2021, 07:08 PM |
Wolchko J Scott | President and CEO | Jan 11, 2021 | Sale | $110.81 | 8,587 | 951,556 | 355,634 | Jan 12, 2021, 08:41 PM |
Wolchko J Scott | President and CEO | Jan 08, 2021 | Sale | $117.10 | 60,820 | 7,122,217 | 393,065 | Jan 12, 2021, 08:41 PM |
Valamehr Bahram | Chief Development Officer | Jan 11, 2021 | Sale | $110.81 | 3,254 | 360,588 | 79,649 | Jan 12, 2021, 08:40 PM |
Valamehr Bahram | Chief Development Officer | Jan 08, 2021 | Sale | $117.10 | 6,230 | 729,552 | 84,455 | Jan 12, 2021, 08:40 PM |
TAHL CINDY | General Counsel and Secretary | Jan 11, 2021 | Sale | $110.81 | 3,254 | 360,587 | 91,957 | Jan 12, 2021, 08:39 PM |
TAHL CINDY | General Counsel and Secretary | Jan 08, 2021 | Sale | $117.10 | 6,229 | 729,434 | 96,763 | Jan 12, 2021, 08:39 PM |
Shoemaker Daniel D | Chief Scientific Officer | Jan 11, 2021 | Sale | $110.81 | 3,253 | 360,477 | 85,530 | Jan 12, 2021, 08:38 PM |
Shoemaker Daniel D | Chief Scientific Officer | Jan 08, 2021 | Sale | $117.10 | 6,229 | 729,434 | 90,336 | Jan 12, 2021, 08:38 PM |
Redmile Group, LLC | Director | Jan 08, 2021 | Buy | $85.50 | 327,485 | 27,999,968 | 12,957,222 | Jan 12, 2021, 04:16 PM |
Wolchko J Scott | President and CEO | Dec 17, 2020 | Option Exercise | $6.62 | 20,000 | 132,400 | 439,969 | Dec 18, 2020, 04:01 PM |
Wolchko J Scott | President and CEO | Dec 17, 2020 | Sale | $91.82 | 20,000 | 1,836,352 | 436,801 | Dec 18, 2020, 04:01 PM |
Valamehr Bahram | Chief Development Officer | Dec 14, 2020 | Option Exercise | $2.90 | 25,000 | 72,500 | 112,211 | Dec 15, 2020, 04:01 PM |
Valamehr Bahram | Chief Development Officer | Dec 14, 2020 | Sale | $97.78 | 25,000 | 2,444,477 | 110,398 | Dec 15, 2020, 04:01 PM |
Shoemaker Daniel D | Chief Scientific Officer | Nov 16, 2020 | Sale | $51.83 | 25,000 | 1,295,746 | 113,159 | Nov 16, 2020, 05:12 PM |
Wolchko J Scott | President and CEO | Nov 12, 2020 | Option Exercise | $2.73 | 30,000 | 81,900 | 449,969 | Nov 16, 2020, 04:02 PM |
Wolchko J Scott | President and CEO | Nov 13, 2020 | Option Exercise | $5.73 | 30,000 | 172,007 | 430,123 | Nov 16, 2020, 04:02 PM |
Wolchko J Scott | President and CEO | Nov 13, 2020 | Sale | $51.03 | 30,000 | 1,530,900 | 419,969 | Nov 16, 2020, 04:02 PM |
Wolchko J Scott | President and CEO | Nov 12, 2020 | Sale | $52.72 | 30,000 | 1,581,524 | 434,767 | Nov 16, 2020, 04:02 PM |
TAHL CINDY | General Counsel and Secretary | Nov 05, 2020 | Option Exercise | $2.82 | 19,282 | 54,340 | 118,800 | Nov 06, 2020, 04:02 PM |
TAHL CINDY | General Counsel and Secretary | Nov 04, 2020 | Option Exercise | $2.73 | 51,519 | 140,647 | 151,037 | Nov 06, 2020, 04:02 PM |
TAHL CINDY | General Counsel and Secretary | Nov 05, 2020 | Sale | $50.63 | 19,282 | 976,252 | 102,118 | Nov 06, 2020, 04:02 PM |
TAHL CINDY | General Counsel and Secretary | Nov 04, 2020 | Sale | $50.41 | 51,519 | 2,597,140 | 99,518 | Nov 06, 2020, 04:02 PM |
TAHL CINDY | General Counsel and Secretary | Oct 16, 2020 | Option Exercise | $2.73 | 29,199 | 79,713 | 128,717 | Oct 20, 2020, 04:01 PM |
TAHL CINDY | General Counsel and Secretary | Oct 16, 2020 | Sale | $50.25 | 29,199 | 1,467,212 | 99,518 | Oct 20, 2020, 04:01 PM |
TAHL CINDY | General Counsel and Secretary | Oct 01, 2020 | Option Exercise | $2.73 | 35,000 | 95,550 | 134,518 | Oct 02, 2020, 12:00 AM |
TAHL CINDY | General Counsel and Secretary | Oct 01, 2020 | Sale | $40.74 | 35,000 | 1,426,065 | 112,761 | Oct 02, 2020, 12:00 AM |
Valamehr Bahram | Chief Development Officer | Sep 14, 2020 | Option Exercise | $2.75 | 25,000 | 68,778 | 112,211 | Sep 16, 2020, 04:02 PM |
Valamehr Bahram | Chief Development Officer | Sep 14, 2020 | Sale | $36.28 | 25,000 | 907,024 | 111,611 | Sep 16, 2020, 04:02 PM |
Shoemaker Daniel D | Chief Scientific Officer | Sep 14, 2020 | Sale | $36.30 | 25,000 | 907,540 | 141,691 | Sep 16, 2020, 04:01 PM |
Redmile Group, LLC | Director | Jun 11, 2020 | Buy | $28.31 | 1,412,928 | 39,999,991 | 12,629,737 | Jun 17, 2020, 08:25 PM |
RASTETTER WILLIAM H | Director | Mar 30, 2020 | Option Exercise | $1.37 | 28,461 | 38,992 | 28,461 | Mar 31, 2020, 04:01 PM |
Valamehr Bahram | Chief Development Officer | Feb 03, 2020 | Option Exercise | $1.69 | 1,153 | 1,949 | 87,211 | Feb 04, 2020, 12:00 AM |
Wolchko J Scott | President and CEO | Jan 30, 2020 | Option Exercise | $2.70 | 25,000 | 67,500 | 444,969 | Feb 03, 2020, 04:01 PM |
Wolchko J Scott | President and CEO | Jan 30, 2020 | Sale | $25.45 | 25,000 | 636,303 | 419,969 | Feb 03, 2020, 04:01 PM |
Valamehr Bahram | Chief Development Officer | Jan 08, 2020 | Sale | $20.69 | 5,700 | 117,947 | 86,058 | Jan 10, 2020, 04:03 PM |
TAHL CINDY | General Counsel and Secretary | Jan 08, 2020 | Sale | $20.72 | 5,700 | 118,085 | 99,518 | Jan 10, 2020, 04:02 PM |
Shoemaker Daniel D | Chief Scientific Officer | Jan 08, 2020 | Sale | $20.70 | 5,700 | 117,986 | 143,091 | Jan 10, 2020, 04:01 PM |
Shoemaker Daniel D | Chief Scientific Officer | Dec 30, 2019 | Option Exercise | $2.90 | 25,000 | 72,500 | 148,791 | Jan 02, 2020, 04:01 PM |
Shoemaker Daniel D | Chief Scientific Officer | Dec 30, 2019 | Sale | $19.50 | 25,000 | 487,427 | 123,891 | Jan 02, 2020, 04:01 PM |
Wolchko J Scott | President and CEO | Dec 20, 2019 | Option Exercise | $2.70 | 25,000 | 67,500 | 378,969 | Dec 23, 2019, 04:02 PM |
Wolchko J Scott | President and CEO | Dec 19, 2019 | Option Exercise | $2.70 | 25,000 | 67,500 | 378,969 | Dec 23, 2019, 04:02 PM |
Wolchko J Scott | President and CEO | Dec 20, 2019 | Sale | $20.17 | 25,000 | 504,157 | 353,969 | Dec 23, 2019, 04:02 PM |
Wolchko J Scott | President and CEO | Dec 19, 2019 | Sale | $20.08 | 25,000 | 501,897 | 353,969 | Dec 23, 2019, 04:02 PM |
Wolchko J Scott | President and CEO | Oct 15, 2019 | Sale | $14.44 | 21,017 | 303,458 | 353,969 | Oct 16, 2019, 04:07 PM |
Valamehr Bahram | Chief Development Officer | Oct 15, 2019 | Sale | $14.18 | 6,200 | 87,891 | 66,758 | Oct 16, 2019, 04:06 PM |
TAHL CINDY | General Counsel and Secretary | Oct 15, 2019 | Sale | $14.24 | 10,200 | 145,292 | 80,218 | Oct 16, 2019, 04:05 PM |
Shoemaker Daniel D | Chief Scientific Officer | Oct 15, 2019 | Sale | $14.29 | 11,800 | 168,593 | 123,791 | Oct 16, 2019, 04:04 PM |
Redmile Group, LLC | Director | Sep 16, 2019 | Buy | $17.50 | 857,143 | 15,000,003 | 11,216,809 | Sep 17, 2019, 04:22 PM |
Nashat Amir | Director | Jul 31, 2019 | Sale | $22.53 | 31,139 | 701,674 | 1,129,554 | Aug 02, 2019, 04:32 PM |
Nashat Amir | Director | Aug 01, 2019 | Sale | $22.53 | 30,866 | 695,392 | 1,099,772 | Aug 02, 2019, 04:32 PM |
Nashat Amir | Director | Jul 30, 2019 | Sale | $22.51 | 90,175 | 2,029,560 | 1,159,599 | Jul 30, 2019, 06:25 PM |
Nashat Amir | Director | Jul 29, 2019 | Sale | $22.50 | 329 | 7,403 | 1,246,609 | Jul 30, 2019, 06:25 PM |
Nashat Amir | Director | Jul 26, 2019 | Sale | $22.50 | 27,829 | 626,153 | 1,246,926 | Jul 30, 2019, 06:25 PM |
Nashat Amir | Director | Jul 24, 2019 | Sale | $22.51 | 19,866 | 447,098 | 1,273,778 | Jul 25, 2019, 06:24 PM |
Nashat Amir | Director | Jul 23, 2019 | Sale | $22.50 | 62,033 | 1,396,053 | 1,292,946 | Jul 25, 2019, 06:24 PM |
Nashat Amir | Director | Jul 19, 2019 | Sale | $22.50 | 1,053 | 23,693 | 1,399,792 | Jul 22, 2019, 05:52 PM |
Nashat Amir | Director | Jul 18, 2019 | Sale | $22.50 | 21,409 | 481,795 | 1,400,808 | Jul 22, 2019, 05:52 PM |
Nashat Amir | Director | Jul 22, 2019 | Sale | $22.52 | 48,704 | 1,097,019 | 1,352,800 | Jul 22, 2019, 05:52 PM |
Shoemaker Daniel D | Chief Scientific Officer | Jun 27, 2019 | Option Exercise | $2.90 | 12,500 | 36,250 | 148,091 | Jun 28, 2019, 04:02 PM |
Shoemaker Daniel D | Chief Scientific Officer | Jun 27, 2019 | Sale | $20.21 | 12,500 | 252,610 | 135,591 | Jun 28, 2019, 04:02 PM |
Wolchko J Scott | President and CEO | May 16, 2019 | Option Exercise | $1.63 | 14,335 | 23,366 | 389,216 | May 17, 2019, 06:27 PM |
Wolchko J Scott | President and CEO | May 16, 2019 | Sale | $19.37 | 14,335 | 277,684 | 386,918 | May 17, 2019, 06:27 PM |
Wolchko J Scott | President and CEO | Apr 18, 2019 | Option Exercise | $1.63 | 11,459 | 18,678 | 381,724 | Apr 19, 2019, 04:13 PM |
Wolchko J Scott | President and CEO | Apr 17, 2019 | Option Exercise | $1.63 | 8,541 | 13,922 | 382,330 | Apr 19, 2019, 04:13 PM |
Wolchko J Scott | President and CEO | Apr 18, 2019 | Sale | $16.01 | 11,459 | 183,509 | 374,881 | Apr 19, 2019, 04:13 PM |
Wolchko J Scott | President and CEO | Apr 17, 2019 | Sale | $16.17 | 8,541 | 138,132 | 374,881 | Apr 19, 2019, 04:13 PM |
Shoemaker Daniel D | Chief Scientific Officer | Mar 28, 2019 | Option Exercise | $2.90 | 12,500 | 36,250 | 148,091 | Mar 29, 2019, 04:01 PM |
Shoemaker Daniel D | Chief Scientific Officer | Mar 28, 2019 | Sale | $16.94 | 12,500 | 211,702 | 135,591 | Mar 29, 2019, 04:01 PM |
Wolchko J Scott | President and CEO | Mar 21, 2019 | Option Exercise | $1.63 | 20,000 | 32,600 | 394,881 | Mar 22, 2019, 04:01 PM |
Wolchko J Scott | President and CEO | Mar 21, 2019 | Sale | $17.61 | 20,000 | 352,160 | 374,881 | Mar 22, 2019, 04:01 PM |
TAHL CINDY | General Counsel and Secretary | Mar 01, 2019 | Option Exercise | $2.90 | 25,000 | 72,500 | 115,418 | Mar 05, 2019, 09:00 AM |
TAHL CINDY | General Counsel and Secretary | Mar 01, 2019 | Sale | $16.15 | 25,000 | 403,697 | 90,418 | Mar 05, 2019, 09:00 AM |
TAHL CINDY | General Counsel and Secretary | Feb 25, 2019 | Option Exercise | $2.90 | 25,000 | 72,500 | 115,418 | Feb 27, 2019, 04:01 PM |
TAHL CINDY | General Counsel and Secretary | Feb 25, 2019 | Sale | $16.07 | 25,000 | 401,820 | 90,418 | Feb 27, 2019, 04:01 PM |
Nashat Amir | Director | Jan 30, 2019 | Sale | $14.16 | 53,017 | 750,959 | 1,474,979 | Feb 01, 2019, 05:02 PM |
Nashat Amir | Director | Jan 29, 2019 | Sale | $14.16 | 97,500 | 1,380,795 | 1,529,622 | Jan 31, 2019, 06:00 PM |
Nashat Amir | Director | Jan 28, 2019 | Sale | $13.78 | 70,000 | 964,768 | 1,626,157 | Jan 30, 2019, 04:10 PM |
Nashat Amir | Director | Jan 25, 2019 | Sale | $14.14 | 90,000 | 1,272,753 | 1,696,859 | Jan 29, 2019, 04:31 PM |
Nashat Amir | Director | Jan 18, 2019 | Sale | $16.28 | 39,483 | 642,834 | 1,785,088 | Jan 23, 2019, 04:32 PM |
TAHL CINDY | General Counsel and Secretary | Jan 07, 2019 | Option Exercise | $2.27 | 25,000 | 56,673 | 70,418 | Jan 09, 2019, 04:03 PM |
TAHL CINDY | General Counsel and Secretary | Jan 07, 2019 | Sale | $16.00 | 25,000 | 400,000 | 45,418 | Jan 09, 2019, 04:03 PM |
Nashat Amir | Director | Dec 20, 2018 | Sale | $12.25 | 33,474 | 410,160 | 1,824,360 | Dec 26, 2018, 04:13 PM |
Nashat Amir | Director | Dec 19, 2018 | Sale | $13.40 | 91,210 | 1,222,592 | 1,882,881 | Dec 21, 2018, 04:12 PM |
Nashat Amir | Director | Dec 13, 2018 | Sale | $16.67 | 17,788 | 296,563 | 1,948,494 | Dec 17, 2018, 04:25 PM |
Nashat Amir | Director | Dec 12, 2018 | Sale | $16.78 | 425,000 | 7,132,690 | 1,980,561 | Dec 14, 2018, 04:33 PM |
Nashat Amir | Director | Dec 11, 2018 | Sale | $16.71 | 82,528 | 1,379,183 | 2,393,552 | Dec 13, 2018, 05:14 PM |
Redmile Group, LLC | Director | Sep 25, 2018 | Buy | $13.50 | 3,703,704 | 50,000,004 | 10,359,666 | Sep 27, 2018, 04:23 PM |
ABBOT STEWART | Chief Development Officer | May 15, 2018 | Option Exercise | $6.62 | 21,054 | 139,411 | 64,917 | May 16, 2018, 05:28 PM |
Wolchko J Scott | President and CEO | Oct 16, 2017 | Sale | $4.07 | 800 | 3,256 | 124,881 | Oct 17, 2017, 04:05 PM |
Wolchko J Scott | President and CEO | Oct 13, 2017 | Sale | $3.87 | 16,368 | 63,344 | 125,681 | Oct 17, 2017, 04:05 PM |
TAHL CINDY | General Counsel and Secretary | Oct 13, 2017 | Sale | $3.83 | 7,591 | 29,074 | 45,918 | Oct 17, 2017, 04:04 PM |
TAHL CINDY | General Counsel and Secretary | Oct 16, 2017 | Sale | $4.10 | 500 | 2,050 | 45,418 | Oct 17, 2017, 04:04 PM |
Shoemaker Daniel D | Chief Scientific Officer | Oct 16, 2017 | Sale | $4.08 | 700 | 2,856 | 90,591 | Oct 17, 2017, 04:04 PM |
Shoemaker Daniel D | Chief Scientific Officer | Oct 13, 2017 | Sale | $3.86 | 12,525 | 48,346 | 91,291 | Oct 17, 2017, 04:04 PM |
Storgard Chris | Chief Medical Officer | Nov 23, 2016 | Buy | $2.66 | 37,593 | 99,997 | 37,593 | Nov 28, 2016, 03:46 PM |
RASTETTER WILLIAM H | Director | Nov 23, 2016 | Buy | $2.66 | 375,939 | 999,998 | 459,272 | Nov 28, 2016, 03:44 PM |
Coughlin Timothy P | Director | Nov 23, 2016 | Buy | $2.66 | 56,390 | 149,997 | 56,390 | Nov 28, 2016, 03:42 PM |
Wolchko J Scott | President and CEO | Aug 23, 2016 | Option Exercise | $1.37 | 2,570 | 3,521 | 142,049 | Aug 24, 2016, 06:55 PM |
Wolchko J Scott | President and CEO | Jan 18, 2016 | Option Exercise | $1.50 | 7,500 | 11,238 | 139,479 | Jan 20, 2016, 02:32 PM |
Wolchko J Scott | See Remarks | Apr 13, 2015 | Option Exercise | $1.47 | 8,000 | 11,723 | 34,773 | Apr 14, 2015, 04:22 PM |
Weyer Christian | See Remarks | Apr 13, 2015 | Option Exercise | $1.37 | 25,000 | 34,250 | 30,429 | Apr 14, 2015, 03:52 PM |
Flynn Peter D | See remarks | Jun 11, 2014 | Option Exercise | $1.63 | 1,017 | 1,658 | 5,056 | Jun 12, 2014, 05:45 PM |
Flynn Peter D | See remarks | Jun 12, 2014 | Option Exercise | $1.61 | 5,471 | 8,808 | 9,510 | Jun 12, 2014, 05:45 PM |
Flynn Peter D | See remarks | Jun 11, 2014 | Sale | $7.00 | 1,017 | 7,119 | 4,039 | Jun 12, 2014, 05:45 PM |
Flynn Peter D | See remarks | Jun 12, 2014 | Sale | $7.00 | 5,471 | 38,297 | 4,039 | Jun 12, 2014, 05:45 PM |
Flynn Peter D | See remarks | Jun 09, 2014 | Option Exercise | $1.63 | 1,260 | 2,054 | 6,645 | Jun 11, 2014, 05:58 PM |
Flynn Peter D | See remarks | Jun 10, 2014 | Option Exercise | $1.63 | 699 | 1,139 | 5,389 | Jun 11, 2014, 05:58 PM |
Flynn Peter D | See remarks | Jun 10, 2014 | Sale | $7.00 | 1,350 | 9,450 | 4,039 | Jun 11, 2014, 05:58 PM |
Flynn Peter D | See remarks | Jun 09, 2014 | Sale | $7.00 | 1,955 | 13,685 | 4,690 | Jun 11, 2014, 05:58 PM |
Flynn Peter D | See remarks | May 01, 2014 | Option Exercise | $1.62 | 25,341 | 40,977 | 15,178 | May 05, 2014, 05:48 PM |
Flynn Peter D | See remarks | May 01, 2014 | Sale | $7.07 | 29,379 | 207,598 | 5,385 | May 05, 2014, 05:48 PM |
Flynn Peter D | See remarks | Apr 04, 2014 | Option Exercise | $1.63 | 5,889 | 9,599 | 12,620 | Apr 07, 2014, 12:39 PM |
Flynn Peter D | See remarks | Apr 04, 2014 | Sale | $8.00 | 5,889 | 47,109 | 6,831 | Apr 07, 2014, 12:39 PM |
Wolchko J Scott | See remarks | Apr 03, 2014 | Option Exercise | $1.37 | 8,862 | 12,141 | 23,888 | Apr 07, 2014, 12:32 PM |
Weyer Christian | See remarks | Apr 02, 2014 | Option Exercise | $1.37 | 2,262 | 3,099 | 2,262 | Apr 03, 2014, 12:55 PM |
Weyer Christian | See remarks | Apr 01, 2014 | Option Exercise | $1.37 | 7,738 | 10,601 | 7,738 | Apr 03, 2014, 12:55 PM |
Weyer Christian | See remarks | Apr 02, 2014 | Sale | $9.02 | 2,262 | 20,395 | 0 | Apr 03, 2014, 12:55 PM |
Weyer Christian | See remarks | Apr 01, 2014 | Sale | $9.02 | 7,738 | 69,789 | 0 | Apr 03, 2014, 12:55 PM |
Shoemaker Daniel D | Chief Technology Officer | Mar 31, 2014 | Sale | $9.86 | 8,653 | 85,361 | 26,362 | Apr 02, 2014, 12:07 PM |
Flynn Peter D | See remarks | Apr 01, 2014 | Sale | $9.05 | 1,346 | 12,177 | 6,731 | Apr 02, 2014, 12:00 PM |
Flynn Peter D | See remarks | Mar 31, 2014 | Sale | $10.16 | 2,692 | 27,348 | 8,377 | Apr 02, 2014, 12:00 PM |
Wolchko J Scott | See remarks | Apr 01, 2014 | Sale | $9.08 | 4,019 | 36,482 | 15,026 | Apr 02, 2014, 11:52 AM |
Wolchko J Scott | See remarks | Mar 31, 2014 | Sale | $9.79 | 15,981 | 156,397 | 19,545 | Apr 02, 2014, 11:52 AM |
VENROCK ASSOCIATES V LP | 10% Owner | Oct 04, 2013 | Option Exercise | $6.00 | 128,447 | 770,682 | 1,639,854 | Oct 07, 2013, 04:18 PM |
VENROCK ASSOCIATES V LP | 10% Owner | Oct 04, 2013 | Buy | $6.00 | 833,333 | 4,999,998 | 2,473,187 | Oct 07, 2013, 04:18 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | Oct 04, 2013 | Option Exercise | $6.00 | 1,239 | 7,434 | 1,639,853 | Oct 07, 2013, 02:17 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | Oct 04, 2013 | Option Exercise | $6.00 | 849 | 5,094 | 1,638,614 | Oct 07, 2013, 02:17 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | Oct 04, 2013 | Option Exercise | $6.00 | 2,415 | 14,490 | 1,637,765 | Oct 07, 2013, 02:17 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | Oct 04, 2013 | Option Exercise | $6.00 | 123,943 | 743,658 | 1,635,350 | Oct 07, 2013, 02:17 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | Oct 04, 2013 | Buy | $6.00 | 15,672 | 94,032 | 2,459,637 | Oct 07, 2013, 02:17 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | Oct 04, 2013 | Buy | $6.00 | 804,112 | 4,824,672 | 2,443,965 | Oct 07, 2013, 02:17 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | Oct 04, 2013 | Buy | $6.00 | 8,041 | 48,246 | 2,473,186 | Oct 07, 2013, 02:17 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | Oct 04, 2013 | Buy | $6.00 | 5,508 | 33,048 | 2,465,145 | Oct 07, 2013, 02:17 PM |
Nashat Amir | Director | Oct 04, 2013 | Option Exercise | $6.00 | 123,943 | 743,658 | 1,635,350 | Oct 07, 2013, 02:07 PM |
Nashat Amir | Director | Oct 04, 2013 | Option Exercise | $6.00 | 1,239 | 7,434 | 1,639,853 | Oct 07, 2013, 02:07 PM |
Nashat Amir | Director | Oct 04, 2013 | Option Exercise | $6.00 | 849 | 5,094 | 1,638,614 | Oct 07, 2013, 02:07 PM |
Nashat Amir | Director | Oct 04, 2013 | Option Exercise | $6.00 | 2,415 | 14,490 | 1,637,765 | Oct 07, 2013, 02:07 PM |
Nashat Amir | Director | Oct 04, 2013 | Buy | $6.00 | 8,041 | 48,246 | 2,473,186 | Oct 07, 2013, 02:07 PM |
Nashat Amir | Director | Oct 04, 2013 | Buy | $6.00 | 5,508 | 33,048 | 2,465,145 | Oct 07, 2013, 02:07 PM |
Nashat Amir | Director | Oct 04, 2013 | Buy | $6.00 | 15,672 | 94,032 | 2,459,637 | Oct 07, 2013, 02:07 PM |
Nashat Amir | Director | Oct 04, 2013 | Buy | $6.00 | 804,112 | 4,824,672 | 2,443,965 | Oct 07, 2013, 02:07 PM |
OVP VENTURE PARTNERS VII LP | 10% Owner | Oct 04, 2013 | Option Exercise | $6.00 | 822 | 4,932 | 1,499,467 | Oct 07, 2013, 02:06 PM |
OVP VENTURE PARTNERS VII LP | 10% Owner | Oct 04, 2013 | Option Exercise | $6.00 | 116,629 | 699,774 | 1,498,645 | Oct 07, 2013, 02:06 PM |
ARCH VENTURE FUND VI LP | 10% Owner | Oct 04, 2013 | Option Exercise | $6.00 | 128,447 | 770,682 | 1,639,855 | Oct 07, 2013, 02:06 PM |
ARCH VENTURE FUND VI LP | 10% Owner | Oct 04, 2013 | Buy | $6.00 | 833,333 | 4,999,998 | 2,473,188 | Oct 07, 2013, 02:06 PM |
NELSEN ROBERT | Director | Oct 04, 2013 | Option Exercise | $6.00 | 128,447 | 770,682 | 1,639,855 | Oct 07, 2013, 02:00 PM |
NELSEN ROBERT | Director | Oct 04, 2013 | Buy | $6.00 | 833,333 | 4,999,998 | 2,473,188 | Oct 07, 2013, 02:00 PM |
RASTETTER WILLIAM H | Director | Oct 04, 2013 | Buy | $6.00 | 83,333 | 499,998 | 83,333 | Oct 07, 2013, 01:59 PM |
MENDLEIN JOHN | Director | Oct 04, 2013 | Buy | $6.00 | 16,667 | 100,002 | 156,774 | Oct 07, 2013, 01:59 PM |
Owner | Relationship | Date | Value($) |
Dulac Edward J III | Chief Financial Officer | 03/04/2024 | 19,013 |
Dulac Edward J III | Chief Financial Officer | 01/29/2024 | 9,245 |
TAHL CINDY | General Counsel and Secretary | 01/09/2024 | 47,519 |
Valamehr Bahram | Chief R&D Officer | 01/09/2024 | 49,367 |
Wolchko J Scott | President and CEO | 01/09/2024 | 62,889 |
Dulac Edward J III | Chief Financial Officer | 01/09/2024 | 30,712 |
Dulac Edward J III | Chief Financial Officer | 01/02/2024 | 18,966 |
Redmile Group, LLC | Director | 12/26/2023 | 12,315,953 |
Redmile Group, LLC | Director | 12/26/2023 | 166,024 |
Dulac Edward J III | Chief Financial Officer | 12/18/2023 | 5,548 |
TAHL CINDY | General Counsel and Secretary | 11/09/2023 | 58,471 |
Dulac Edward J III | Chief Financial Officer | 08/18/2023 | 13,210 |
Xu Yuan | Director | 08/04/2023 | 2,345 |
Powl Brian T. | Chief Commercial Officer | 07/05/2023 | 18,769 |
Dulac Edward J III | Chief Financial Officer | 07/05/2023 | 25,029 |
Xu Yuan | Director | 06/14/2023 | 19,307 |
Redmile Group, LLC | Director | 04/21/2023 | 1,586,029 |
Redmile Group, LLC | Director | 04/20/2023 | 119,800 |
Chu Yu-Waye | Chief Medical Officer | 04/18/2023 | 16,648 |
Redmile Group, LLC | Director | 04/14/2023 | 64,151,058 |
Redmile Group, LLC | Director | 04/14/2023 | 154,200 |
Redmile Group, LLC | Director | 04/14/2023 | 1,765,660 |
MENDLEIN JOHN | Director | 01/19/2023 | 38,992 |
MENDLEIN JOHN | Director | 01/13/2023 | 198,906 |
MENDLEIN JOHN | Director | 01/11/2023 | 499,232 |
Valamehr Bahram | Chief R&D Officer | 01/12/2023 | 580 |
Wolchko J Scott | President and CEO | 01/10/2023 | 240,553 |
Valamehr Bahram | Chief R&D Officer | 01/10/2023 | 57,205 |
TAHL CINDY | General Counsel and Secretary | 01/10/2023 | 60,538 |
Plavsic Mark | Chief Technical Officer | 01/10/2023 | 17,910 |
Dulac Edward J III | Chief Financial Officer | 01/10/2023 | 38,414 |
Chu Yu-Waye | Chief Medical Officer | 01/10/2023 | 41,003 |
Dulac Edward J III | Chief Financial Officer | 08/18/2022 | 153,051 |
Wolchko J Scott | President and CEO | 07/22/2022 | 16,864 |
Wolchko J Scott | President and CEO | 07/21/2022 | 81,000 |
Wolchko J Scott | President and CEO | 07/21/2022 | 986,361 |
Wolchko J Scott | President and CEO | 07/22/2022 | 200,356 |
Valamehr Bahram | Chief R&D Officer | 07/07/2022 | 46,841 |
Valamehr Bahram | Chief R&D Officer | 07/07/2022 | 518,686 |
Valamehr Bahram | Chief R&D Officer | 07/06/2022 | 25,629 |
Valamehr Bahram | Chief R&D Officer | 07/06/2022 | 235,809 |
Agarwal Shefali | Director | 06/07/2022 | 18,409 |
MENDLEIN JOHN | Director | 06/03/2022 | 31,086 |
Jooss Karin | Director | 06/03/2022 | 33,842 |
HERSHBERG ROBERT | Director | 06/03/2022 | 15,288 |
COUGHLIN TIMOTHY | Director | 06/03/2022 | 32,824 |
Agarwal Shefali | Director | 06/03/2022 | 18,400 |
TAHL CINDY | General Counsel and Secretary | 06/01/2022 | 163,750 |
TAHL CINDY | General Counsel and Secretary | 06/01/2022 | 574,000 |
Wolchko J Scott | President and CEO | 04/22/2022 | 27,000 |
Wolchko J Scott | President and CEO | 04/21/2022 | 81,000 |
Wolchko J Scott | President and CEO | 04/22/2022 | 345,911 |
Wolchko J Scott | President and CEO | 04/21/2022 | 1,049,881 |
Chu Yu-Waye | Chief Medical Officer | 04/19/2022 | 143,673 |
Valamehr Bahram | Chief R&D Officer | 03/14/2022 | 68,250 |
Valamehr Bahram | Chief R&D Officer | 03/14/2022 | 776,733 |
MENDLEIN JOHN | Director | 03/10/2022 | 51,446 |
MENDLEIN JOHN | Director | 03/10/2022 | 1,105,200 |
Wolchko J Scott | President and CEO | 01/20/2022 | 81,000 |
Wolchko J Scott | President and CEO | 01/21/2022 | 27,000 |
Wolchko J Scott | President and CEO | 01/20/2022 | 81,900 |
Wolchko J Scott | President and CEO | 01/21/2022 | 380,200 |
Wolchko J Scott | President and CEO | 01/20/2022 | 1,206,300 |
Wolchko J Scott | President and CEO | 01/11/2022 | 709,027 |
TAHL CINDY | General Counsel and Secretary | 01/11/2022 | 262,975 |
Valamehr Bahram | Chief R&D Officer | 01/11/2022 | 221,655 |
Dulac Edward J III | Chief Financial Officer | 01/11/2022 | 85,757 |
Chu Yu-Waye | Senior VP Clinical Development | 01/11/2022 | 192,340 |
Wolchko J Scott | President and CEO | 01/10/2022 | 1,600,534 |
TAHL CINDY | General Counsel and Secretary | 01/10/2022 | 359,313 |
Valamehr Bahram | Chief R&D Officer | 01/10/2022 | 259,558 |
TAHL CINDY | General Counsel and Secretary | 01/03/2022 | 327,500 |
TAHL CINDY | General Counsel and Secretary | 01/03/2022 | 2,966,853 |
Dulac Edward J III | Chief Financial Officer | 12/20/2021 | 512,802 |
Dulac Edward J III | Chief Financial Officer | 12/20/2021 | 958,620 |
Valamehr Bahram | Chief R&D Officer | 12/13/2021 | 68,250 |
Valamehr Bahram | Chief R&D Officer | 12/13/2021 | 1,191,406 |
Chu Yu-Waye | Senior VP Clinical Development | 12/10/2021 | 122,400 |
Chu Yu-Waye | Senior VP Clinical Development | 12/10/2021 | 385,948 |
Wolchko J Scott | President and CEO | 11/18/2021 | 54,000 |
Wolchko J Scott | President and CEO | 11/18/2021 | 1,085,400 |
Wolchko J Scott | President and CEO | 10/22/2021 | 91,670 |
Wolchko J Scott | President and CEO | 10/21/2021 | 81,900 |
Wolchko J Scott | President and CEO | 10/22/2021 | 1,766,400 |
Wolchko J Scott | President and CEO | 10/21/2021 | 1,806,560 |
TAHL CINDY | General Counsel and Secretary | 10/01/2021 | 327,500 |
TAHL CINDY | General Counsel and Secretary | 10/01/2021 | 2,941,462 |
Dulac Edward J III | Chief Financial Officer | 09/28/2021 | 615,384 |
Dulac Edward J III | Chief Financial Officer | 09/28/2021 | 1,216,834 |
Valamehr Bahram | Chief Development Officer | 09/13/2021 | 68,250 |
Valamehr Bahram | Chief Development Officer | 09/13/2021 | 1,657,257 |
Wolchko J Scott | President and CEO | 08/19/2021 | 96,700 |
Wolchko J Scott | President and CEO | 08/19/2021 | 1,760,204 |
Dulac Edward J III | Chief Financial Officer | 08/19/2021 | 306,602 |
Wolchko J Scott | President and CEO | 07/23/2021 | 124,100 |
Wolchko J Scott | President and CEO | 07/22/2021 | 81,900 |
Wolchko J Scott | President and CEO | 07/23/2021 | 2,558,538 |
Wolchko J Scott | President and CEO | 07/22/2021 | 2,581,575 |
TAHL CINDY | General Counsel and Secretary | 07/01/2021 | 313,242 |
TAHL CINDY | General Counsel and Secretary | 07/01/2021 | 4,733,743 |
Chu Yu-Waye | Senior VP Clinical Development | 04/16/2021 | 272,809 |
TAHL CINDY | See Remarks | 04/01/2021 | 96,199 |
TAHL CINDY | See Remarks | 04/01/2021 | 2,514,329 |
Valamehr Bahram | Chief Development Officer | 03/15/2021 | 72,500 |
Valamehr Bahram | Chief Development Officer | 03/15/2021 | 2,308,772 |
Shoemaker Daniel D | Chief Scientific Officer | 03/08/2021 | 2,043,428 |
Wolchko J Scott | President and CEO | 02/18/2021 | 132,400 |
Wolchko J Scott | President and CEO | 02/18/2021 | 2,040,256 |
Wolchko J Scott | President and CEO | 01/21/2021 | 81,900 |
Wolchko J Scott | President and CEO | 01/22/2021 | 159,700 |
Wolchko J Scott | President and CEO | 01/22/2021 | 2,948,613 |
Wolchko J Scott | President and CEO | 01/21/2021 | 3,091,361 |
TAHL CINDY | General Counsel and Secretary | 01/19/2021 | 101,500 |
TAHL CINDY | General Counsel and Secretary | 01/19/2021 | 4,016,643 |
Wolchko J Scott | President and CEO | 01/11/2021 | 951,556 |
Wolchko J Scott | President and CEO | 01/08/2021 | 7,122,217 |
Valamehr Bahram | Chief Development Officer | 01/11/2021 | 360,588 |
Valamehr Bahram | Chief Development Officer | 01/08/2021 | 729,552 |
TAHL CINDY | General Counsel and Secretary | 01/11/2021 | 360,587 |
TAHL CINDY | General Counsel and Secretary | 01/08/2021 | 729,434 |
Shoemaker Daniel D | Chief Scientific Officer | 01/11/2021 | 360,477 |
Shoemaker Daniel D | Chief Scientific Officer | 01/08/2021 | 729,434 |
Redmile Group, LLC | Director | 01/08/2021 | 27,999,968 |
Wolchko J Scott | President and CEO | 12/17/2020 | 132,400 |
Wolchko J Scott | President and CEO | 12/17/2020 | 1,836,352 |
Valamehr Bahram | Chief Development Officer | 12/14/2020 | 72,500 |
Valamehr Bahram | Chief Development Officer | 12/14/2020 | 2,444,477 |
Shoemaker Daniel D | Chief Scientific Officer | 11/16/2020 | 1,295,746 |
Wolchko J Scott | President and CEO | 11/12/2020 | 81,900 |
Wolchko J Scott | President and CEO | 11/13/2020 | 172,007 |
Wolchko J Scott | President and CEO | 11/13/2020 | 1,530,900 |
Wolchko J Scott | President and CEO | 11/12/2020 | 1,581,524 |
TAHL CINDY | General Counsel and Secretary | 11/05/2020 | 54,340 |
TAHL CINDY | General Counsel and Secretary | 11/04/2020 | 140,647 |
TAHL CINDY | General Counsel and Secretary | 11/05/2020 | 976,252 |
TAHL CINDY | General Counsel and Secretary | 11/04/2020 | 2,597,140 |
TAHL CINDY | General Counsel and Secretary | 10/16/2020 | 79,713 |
TAHL CINDY | General Counsel and Secretary | 10/16/2020 | 1,467,212 |
TAHL CINDY | General Counsel and Secretary | 10/01/2020 | 95,550 |
TAHL CINDY | General Counsel and Secretary | 10/01/2020 | 1,426,065 |
Valamehr Bahram | Chief Development Officer | 09/14/2020 | 68,778 |
Valamehr Bahram | Chief Development Officer | 09/14/2020 | 907,024 |
Shoemaker Daniel D | Chief Scientific Officer | 09/14/2020 | 907,540 |
Redmile Group, LLC | Director | 06/11/2020 | 39,999,991 |
RASTETTER WILLIAM H | Director | 03/30/2020 | 38,992 |
Valamehr Bahram | Chief Development Officer | 02/03/2020 | 1,949 |
Wolchko J Scott | President and CEO | 01/30/2020 | 67,500 |
Wolchko J Scott | President and CEO | 01/30/2020 | 636,303 |
Valamehr Bahram | Chief Development Officer | 01/08/2020 | 117,947 |
TAHL CINDY | General Counsel and Secretary | 01/08/2020 | 118,085 |
Shoemaker Daniel D | Chief Scientific Officer | 01/08/2020 | 117,986 |
Shoemaker Daniel D | Chief Scientific Officer | 12/30/2019 | 72,500 |
Shoemaker Daniel D | Chief Scientific Officer | 12/30/2019 | 487,427 |
Wolchko J Scott | President and CEO | 12/20/2019 | 67,500 |
Wolchko J Scott | President and CEO | 12/19/2019 | 67,500 |
Wolchko J Scott | President and CEO | 12/20/2019 | 504,157 |
Wolchko J Scott | President and CEO | 12/19/2019 | 501,897 |
Wolchko J Scott | President and CEO | 10/15/2019 | 303,458 |
Valamehr Bahram | Chief Development Officer | 10/15/2019 | 87,891 |
TAHL CINDY | General Counsel and Secretary | 10/15/2019 | 145,292 |
Shoemaker Daniel D | Chief Scientific Officer | 10/15/2019 | 168,593 |
Redmile Group, LLC | Director | 09/16/2019 | 15,000,003 |
Nashat Amir | Director | 07/31/2019 | 701,674 |
Nashat Amir | Director | 08/01/2019 | 695,392 |
Nashat Amir | Director | 07/30/2019 | 2,029,560 |
Nashat Amir | Director | 07/29/2019 | 7,403 |
Nashat Amir | Director | 07/26/2019 | 626,153 |
Nashat Amir | Director | 07/24/2019 | 447,098 |
Nashat Amir | Director | 07/23/2019 | 1,396,053 |
Nashat Amir | Director | 07/19/2019 | 23,693 |
Nashat Amir | Director | 07/18/2019 | 481,795 |
Nashat Amir | Director | 07/22/2019 | 1,097,019 |
Shoemaker Daniel D | Chief Scientific Officer | 06/27/2019 | 36,250 |
Shoemaker Daniel D | Chief Scientific Officer | 06/27/2019 | 252,610 |
Wolchko J Scott | President and CEO | 05/16/2019 | 23,366 |
Wolchko J Scott | President and CEO | 05/16/2019 | 277,684 |
Wolchko J Scott | President and CEO | 04/18/2019 | 18,678 |
Wolchko J Scott | President and CEO | 04/17/2019 | 13,922 |
Wolchko J Scott | President and CEO | 04/18/2019 | 183,509 |
Wolchko J Scott | President and CEO | 04/17/2019 | 138,132 |
Shoemaker Daniel D | Chief Scientific Officer | 03/28/2019 | 36,250 |
Shoemaker Daniel D | Chief Scientific Officer | 03/28/2019 | 211,702 |
Wolchko J Scott | President and CEO | 03/21/2019 | 32,600 |
Wolchko J Scott | President and CEO | 03/21/2019 | 352,160 |
TAHL CINDY | General Counsel and Secretary | 03/01/2019 | 72,500 |
TAHL CINDY | General Counsel and Secretary | 03/01/2019 | 403,697 |
TAHL CINDY | General Counsel and Secretary | 02/25/2019 | 72,500 |
TAHL CINDY | General Counsel and Secretary | 02/25/2019 | 401,820 |
Nashat Amir | Director | 01/30/2019 | 750,959 |
Nashat Amir | Director | 01/29/2019 | 1,380,795 |
Nashat Amir | Director | 01/28/2019 | 964,768 |
Nashat Amir | Director | 01/25/2019 | 1,272,753 |
Nashat Amir | Director | 01/18/2019 | 642,834 |
TAHL CINDY | General Counsel and Secretary | 01/07/2019 | 56,673 |
TAHL CINDY | General Counsel and Secretary | 01/07/2019 | 400,000 |
Nashat Amir | Director | 12/20/2018 | 410,160 |
Nashat Amir | Director | 12/19/2018 | 1,222,592 |
Nashat Amir | Director | 12/13/2018 | 296,563 |
Nashat Amir | Director | 12/12/2018 | 7,132,690 |
Nashat Amir | Director | 12/11/2018 | 1,379,183 |
Redmile Group, LLC | Director | 09/25/2018 | 50,000,004 |
ABBOT STEWART | Chief Development Officer | 05/15/2018 | 139,411 |
Wolchko J Scott | President and CEO | 10/16/2017 | 3,256 |
Wolchko J Scott | President and CEO | 10/13/2017 | 63,344 |
TAHL CINDY | General Counsel and Secretary | 10/13/2017 | 29,074 |
TAHL CINDY | General Counsel and Secretary | 10/16/2017 | 2,050 |
Shoemaker Daniel D | Chief Scientific Officer | 10/16/2017 | 2,856 |
Shoemaker Daniel D | Chief Scientific Officer | 10/13/2017 | 48,346 |
Storgard Chris | Chief Medical Officer | 11/23/2016 | 99,997 |
RASTETTER WILLIAM H | Director | 11/23/2016 | 999,998 |
Coughlin Timothy P | Director | 11/23/2016 | 149,997 |
Wolchko J Scott | President and CEO | 08/23/2016 | 3,521 |
Wolchko J Scott | President and CEO | 01/18/2016 | 11,238 |
Wolchko J Scott | See Remarks | 04/13/2015 | 11,723 |
Weyer Christian | See Remarks | 04/13/2015 | 34,250 |
Flynn Peter D | See remarks | 06/11/2014 | 1,658 |
Flynn Peter D | See remarks | 06/12/2014 | 8,808 |
Flynn Peter D | See remarks | 06/11/2014 | 7,119 |
Flynn Peter D | See remarks | 06/12/2014 | 38,297 |
Flynn Peter D | See remarks | 06/09/2014 | 2,054 |
Flynn Peter D | See remarks | 06/10/2014 | 1,139 |
Flynn Peter D | See remarks | 06/10/2014 | 9,450 |
Flynn Peter D | See remarks | 06/09/2014 | 13,685 |
Flynn Peter D | See remarks | 05/01/2014 | 40,977 |
Flynn Peter D | See remarks | 05/01/2014 | 207,598 |
Flynn Peter D | See remarks | 04/04/2014 | 9,599 |
Flynn Peter D | See remarks | 04/04/2014 | 47,109 |
Wolchko J Scott | See remarks | 04/03/2014 | 12,141 |
Weyer Christian | See remarks | 04/02/2014 | 3,099 |
Weyer Christian | See remarks | 04/01/2014 | 10,601 |
Weyer Christian | See remarks | 04/02/2014 | 20,395 |
Weyer Christian | See remarks | 04/01/2014 | 69,789 |
Shoemaker Daniel D | Chief Technology Officer | 03/31/2014 | 85,361 |
Flynn Peter D | See remarks | 04/01/2014 | 12,177 |
Flynn Peter D | See remarks | 03/31/2014 | 27,348 |
Wolchko J Scott | See remarks | 04/01/2014 | 36,482 |
Wolchko J Scott | See remarks | 03/31/2014 | 156,397 |
VENROCK ASSOCIATES V LP | 10% Owner | 10/04/2013 | 770,682 |
VENROCK ASSOCIATES V LP | 10% Owner | 10/04/2013 | 4,999,998 |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | 10/04/2013 | 7,434 |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | 10/04/2013 | 5,094 |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | 10/04/2013 | 14,490 |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | 10/04/2013 | 743,658 |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | 10/04/2013 | 94,032 |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | 10/04/2013 | 4,824,672 |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | 10/04/2013 | 48,246 |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | 10/04/2013 | 33,048 |
Nashat Amir | Director | 10/04/2013 | 743,658 |
Nashat Amir | Director | 10/04/2013 | 7,434 |
Nashat Amir | Director | 10/04/2013 | 5,094 |
Nashat Amir | Director | 10/04/2013 | 14,490 |
Nashat Amir | Director | 10/04/2013 | 48,246 |
Nashat Amir | Director | 10/04/2013 | 33,048 |
Nashat Amir | Director | 10/04/2013 | 94,032 |
Nashat Amir | Director | 10/04/2013 | 4,824,672 |
OVP VENTURE PARTNERS VII LP | 10% Owner | 10/04/2013 | 4,932 |
OVP VENTURE PARTNERS VII LP | 10% Owner | 10/04/2013 | 699,774 |
ARCH VENTURE FUND VI LP | 10% Owner | 10/04/2013 | 770,682 |
ARCH VENTURE FUND VI LP | 10% Owner | 10/04/2013 | 4,999,998 |
NELSEN ROBERT | Director | 10/04/2013 | 770,682 |
NELSEN ROBERT | Director | 10/04/2013 | 4,999,998 |
RASTETTER WILLIAM H | Director | 10/04/2013 | 499,998 |
MENDLEIN JOHN | Director | 10/04/2013 | 100,002 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 11,212,816 | 0.00107% | -10.19% | Other |
D. E. SHAW & CO., INC. | 3,581,979 | 0.01% | -23.98% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,863,485 | 0.00073% | 4.96% | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,700,000 | 0.01% | New | Other |
ORBIMED ADVISORS LLC | 528,080 | 0.04% | New | Other |
AQR CAPITAL MANAGEMENT LLC | 235,058 | 0.00165% | -29.39% | Other |
BRUCE & CO., INC. | 143,000 | 0.19% | -28.5% | Value |
ROYCE & ASSOCIATES LP | 107,318 | 0.00371% | 253.73% | Value |
BALYASNY ASSET MANAGEMENT L.P. | 39,836 | 0.00028% | -72.74% | Event Driven |
Period of Report: 12/31/2023
10-K/10-Q Filings: View